BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 22403496)

  • 1. Optimization of stent deployment by intravascular ultrasound.
    Yoon HJ; Hur SH
    Korean J Intern Med; 2012 Mar; 27(1):30-8. PubMed ID: 22403496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
    Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does IVUS guidance of coronary interventions affect outcome? a prime example of the failure of randomized clinical trials.
    Gerber R; Colombo A
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):646-54. PubMed ID: 18360858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary clinical applications of coronary intravascular ultrasound.
    McDaniel MC; Eshtehardi P; Sawaya FJ; Douglas JS; Samady H
    JACC Cardiovasc Interv; 2011 Nov; 4(11):1155-67. PubMed ID: 22115655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents.
    Claessen BE; Mehran R; Mintz GS; Weisz G; Leon MB; Dogan O; de Ribamar Costa J; Stone GW; Apostolidou I; Morales A; Chantziara V; Syros G; Sanidas E; Xu K; Tijssen JG; Henriques JP; Piek JJ; Moses JW; Maehara A; Dangas GD
    JACC Cardiovasc Interv; 2011 Sep; 4(9):974-81. PubMed ID: 21939937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravascular ultrasound-guided percutaneous coronary interventions in contemporary practice.
    Bonello L; De Labriolle A; Lemesle G; Roy P; Steinberg DH; Pichard AD; Waksman R
    Arch Cardiovasc Dis; 2009 Feb; 102(2):143-51. PubMed ID: 19303582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents.
    Roy P; Steinberg DH; Sushinsky SJ; Okabe T; Pinto Slottow TL; Kaneshige K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Weissman NJ; Lindsay J; Waksman R
    Eur Heart J; 2008 Aug; 29(15):1851-7. PubMed ID: 18550555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term health outcome and mortality evaluation after invasive coronary treatment using drug eluting stents with or without the IVUS guidance. Randomized control trial. HOME DES IVUS.
    Jakabcin J; Spacek R; Bystron M; Kvasnák M; Jager J; Veselka J; Kala P; Cervinka P
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):578-83. PubMed ID: 19902491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiographic and intravascular ultrasound findings following implantation of the Endeavor zotarolimus-eluting stents in patients from the real-world clinical practice.
    Feres F; Andrade PB; Costa RA; de Ribamar Costa J; Abizaid A; Staico R; Tanajura LF; Siqueira D; Maia JP; Lasave L; Sousa AG; Sousa JE
    EuroIntervention; 2009 Aug; 5(3):355-62. PubMed ID: 19736161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial of angiography versus intravascular ultrasound-directed bare-metal coronary stent placement (the AVID Trial).
    Russo RJ; Silva PD; Teirstein PS; Attubato MJ; Davidson CJ; DeFranco AC; Fitzgerald PJ; Goldberg SL; Hermiller JB; Leon MB; Ling FS; Lucisano JE; Schatz RA; Wong SC; Weissman NJ; Zientek DM;
    Circ Cardiovasc Interv; 2009 Apr; 2(2):113-23. PubMed ID: 20031704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravascular ultrasound optimization of drug-eluting stents: still not enough data.
    Leesar MA
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):584-5. PubMed ID: 20333656
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravascular ultrasound-guided drug-eluting stent implantation is associated with improved clinical outcomes in patients with unstable angina and complex coronary artery true bifurcation lesions.
    Chen L; Xu T; Xue XJ; Zhang JJ; Ye F; Tian NL; Chen SL
    Int J Cardiovasc Imaging; 2018 Nov; 34(11):1685-1696. PubMed ID: 29981016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of a drug-eluting balloon first and then bare metal stent with a drug-eluting stent for treatment of de novo lesions: study protocol of a randomized controlled trial.
    Park SD; Yoon CH; Oh IY; Suh JW; Cho YS; Youn TJ; Choi DJ; Chae IH
    Trials; 2013 Feb; 14():38. PubMed ID: 23394404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravascular ultrasound and drug-eluting stents. Where are we now?
    Alfonso F; Dutary J; Rodriguez V; Zakhem B
    Minerva Cardioangiol; 2010 Feb; 58(1):61-78. PubMed ID: 20145596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of drug-eluting stents and bioresorbable stents by grayscale IVUS and IVUS-based imaging modalities.
    Brugaletta S; Costa JR; Garcia-Garcia HM
    Int J Cardiovasc Imaging; 2011 Feb; 27(2):239-48. PubMed ID: 21279692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).
    Kandzari DE; Mauri L; Popma JJ; Turco MA; Gurbel PA; Fitzgerald PJ; Leon MB
    JACC Cardiovasc Interv; 2011 May; 4(5):543-50. PubMed ID: 21596327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial.
    Stella PR; Belkacemi A; Dubois C; Nathoe H; Dens J; Naber C; Adriaenssens T; van Belle E; Doevendans P; Agostoni P
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1138-46. PubMed ID: 22422607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. My stent is better than your stent...Or is it?
    Bates ER; Menees DS
    JACC Cardiovasc Interv; 2011 May; 4(5):551-3. PubMed ID: 21596328
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of intravascular ultrasound-guided adjuvant high-pressure non-compliant balloon post-dilation after drug-eluting stent implantation.
    Muraoka Y; Sonoda S; Tsuda Y; Tanaka S; Okazaki M; Otsuji Y
    Heart Vessels; 2011 Nov; 26(6):565-71. PubMed ID: 21181171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis.
    Kokkinidis DG; Prouse AF; Avner SJ; Lee JM; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2018 Aug; 92(2):285-299. PubMed ID: 29024274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.